AGP Executive Report
Last update: 4 hours agoEbola Crisis Escalates: DR Congo’s Ebola outbreak has spread to two more provinces, Haut-Uele and Tshopo, pushing confirmed cases to about 1,926 and deaths to 702, as officials say the new areas should be treated as an epidemic zone. Vaccine Push: Oxford has launched the first human trial of a Bundibugyo Ebola vaccine (ChAdOx1 BDBV) in the UK, with volunteers being recruited for safety and immune response testing, while another experimental approach (NanoViricides’ NV-387) has gained ethics approval for a Phase II trial in DRC. International Evacuations: Two U.S. citizens infected in Congo have been transferred to Germany for treatment, with hospitals stressing strict isolation and low risk to the public. US Travel Pressure: The U.S. has urged Americans not to travel to DR Congo due to Ebola, warning of possible quarantine costs, and it has paused visa operations for the region. Mining & Trade: Cabinet approved a corridor committee headquarters deal to boost access to Namibia’s Walvis Bay port, while Tshisekedi ordered tougher mining enforcement to be avoided to protect investor confidence; Congo also moved to rehabilitate the Lobito rail link with Portugal’s Mota-Engil.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.